A review of GC suggested that higher tumor marker levels indicate larger tumors, greater serosal attack and elevated rates of metastases (Abbas et al., 2017), which may be caused by greater dysfunction of cell-cycle regulators (i.e., the p53 gene, the enzyme Pin1 and the Wnt signaling pathway, as mentioned above). This evidence concerns the gene TP53 and gastric cancer.